Do you support this bill?

Assembly Bill A5603B

2019-2020 Legislative Session

Relates to prescribing an opioid antagonist with a patient's first opioid prescription each year

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

Bill Amendments

co-Sponsors

multi-Sponsors

2019-A5603 - Details

See Senate Version of this Bill:
S5150
Current Committee:
Assembly Ways And Means
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
A336, S2966

2019-A5603 - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

2019-A5603 - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5603
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 13, 2019
                                ___________
 
 Introduced  by M. of A. BRAUNSTEIN, DINOWITZ, OTIS -- Multi-Sponsored by
   -- M. of A.  McDONOUGH -- read once and referred to the  Committee  on
   Health
 
 AN  ACT  to  amend  the public health law, in relation to prescribing an
   opioid antagonist with a patient's first opioid analgesic prescription
   in a given year

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3302 of the public health law is amended by adding
 two new subdivisions 44 and 45 to read as follows:
   44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
 CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
 MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE,  PROPOXYPHENE
 AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
   45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST  IS  LIMITED  TO
 NALOXONE  OR  OTHER  MEDICATIONS  APPROVED  BY  THE  DEPARTMENT FOR THIS
 PURPOSE.
   § 2. Section 3309 of the public health law is amended by adding a  new
 subdivision 7 to read as follows:
   7.  (A)  WITH  THE FIRST OPIOID ANALGESIC OF EACH YEAR, THE PRESCRIBER
 SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN  ANY  OF  THE  FOLLOWING  RISK
 FACTORS  ARE  PRESENT: A HISTORY OF SUBSTANCE USE DISORDER; HIGH DOSE OR
 CUMULATIVE PRESCRIPTIONS THAT RESULT IN OVER  FIFTY  MORPHINE  MILLIGRAM
 EQUIVALENTS  PER  DAY;  CONCURRENT  USE OF OPIOIDS AND BENZODIAZEPINE OR
 NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
   (B) A PRESCRIBER WHO FAILS  TO  PRESCRIBE  AN  OPIOID  ANTAGONIST,  AS
 REQUIRED  BY  THIS  SUBDIVISION,  SHALL  BE  REFERRED TO THE APPROPRIATE
 LICENSING BOARD SOLELY FOR THE IMPOSITION  OF  ADMINISTRATIVE  SANCTIONS
 DEEMED  APPROPRIATE  BY  SUCH  BOARD.  THIS  SECTION  SHALL NOT CREATE A
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

co-Sponsors

multi-Sponsors

2019-A5603A - Details

See Senate Version of this Bill:
S5150
Current Committee:
Assembly Ways And Means
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
A336, S2966

2019-A5603A - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

2019-A5603A - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  5603--A
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 13, 2019
                                ___________
 
 Introduced  by M. of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ -- Multi-
   Sponsored by -- M. of A. McDONOUGH -- read once and  referred  to  the
   Committee  on  Health  --  committee discharged, bill amended, ordered
   reprinted as amended and recommitted to said committee
 
 AN ACT to amend the public health law, in  relation  to  prescribing  an
   opioid  antagonist  with  a  patient's  first opioid prescription in a
   given year
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3309 of the public health law is amended by adding
 a new subdivision 7 to read as follows:
   7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
 EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR  NURSING
 HOME  UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI-
 CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW, THE PRESCRIBER SHALL PRESCRIBE
 AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOWING RISK FACTORS ARE PRESENT:
 (A) A HISTORY OF SUBSTANCE USE DISORDER; (B)  HIGH  DOSE  OR  CUMULATIVE
 PRESCRIPTIONS  THAT  RESULT IN OVER FIFTY MORPHINE MILLIGRAM EQUIVALENTS
 PER DAY; (C) CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINE  OR  NONBENZO-
 DIAZEPINE SEDATIVE HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it  shall have become a law. Effective immediately, the addition, amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation of this act on its effective date are authorized to be  made  and
 completed  by  the  commissioner  of  health on or before such effective
 date.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD01771-07-9

co-Sponsors

multi-Sponsors

2019-A5603B (ACTIVE) - Details

See Senate Version of this Bill:
S5150
Current Committee:
Assembly Ways And Means
Law Section:
Public Health Law
Laws Affected:
Amd §3309, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
A336, S2966

2019-A5603B (ACTIVE) - Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

2019-A5603B (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  5603--B
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 13, 2019
                                ___________
 
 Introduced  by  M.  of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ, AUBRY,
   RAIA, JAFFEE, L. ROSENTHAL, FERNANDEZ -- Multi-Sponsored by --  M.  of
   A.  McDONOUGH  -- read once and referred to the Committee on Health --
   committee discharged, bill amended, ordered reprinted as  amended  and
   recommitted  to said committee -- reported and referred to the Commit-
   tee on Ways and Means -- committee discharged, bill  amended,  ordered
   reprinted as amended and recommitted to said committee
 
 AN  ACT  to  amend  the public health law, in relation to prescribing an
   opioid antagonist with a patient's  first  opioid  prescription  in  a
   given year
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 3309 of the public health law is amended by  adding
 a new subdivision 7 to read as follows:
   7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF
 EACH  YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR NURSING
 HOME UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER  ARTI-
 CLE  THIRTY-ONE  OF  THE  MENTAL  HYGIENE LAW, OR WHEN A PRACTITIONER IS
 PRESCRIBING A CONTROLLED SUBSTANCE  TO  A  PATIENT  UNDER  THE  CARE  OF
 HOSPICE  AS  DEFINED  BY  SECTION FOUR THOUSAND TWO OF THIS CHAPTER, THE
 PRESCRIBER SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE  FOLLOW-
 ING  RISK  FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE USE DISORDER;
 (B) HIGH DOSE OR CUMULATIVE PRESCRIPTIONS  THAT  RESULT  IN  OVER  FIFTY
 MORPHINE  MILLIGRAM  EQUIVALENTS  PER DAY; (C) CONCURRENT USE OF OPIOIDS
 AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law. Effective immediately, the addition,  amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed by the commissioner of health  on  or  before  such  effective
 date.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.